Camcevi Etm Injection, Emulsion
Product Images NDC 72851-100

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Camcevi Etm (NDC 72851-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Foresee Pharmaceuticals Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image1 (Camcevi Inj Image 1)

CAMCEVI ETM leuprolide 21 mg/.3g injection, emulsion in a single-use syringe for subcutaneous administration. The image shows a top view of the sterile packaging containing the syringe with attached needle, manufactured by Foresee Pharmaceuticals Co., Ltd.*

FDA Label Image

Image2 (Camcevi Inj Image 2)

The image shows a packaging label for CAMCEVI ETM injection, emulsion, containing leuprolide at a strength of 21 mg/.3g. The label features a simple design with a blue abstract shape and two small upward-pointing arrow symbols beneath it. The label is primarily white with minimal text, representing a subcutaneous dosage form by Foresee Pharmaceuticals Co., Ltd.*

FDA Label Image

Image3 (Camcevi Inj Image 3)

Illustration showing two parts labeled A and B for the CAMCEVI ETM subcutaneous injection, leuprolide 21 mg/.3g emulsion. Part A depicts a syringe-like injector device. Part B shows a gloved hand holding a cartridge or vial component, indicating assembly or preparation steps for the injection.*

FDA Label Image

Image4 (Camcevi Inj Image 4)

An instructional illustration showing the connection of two parts labeled A and B, with hands demonstrating twisting or screwing them together. It appears to be related to assembling or preparing a medical injection device, likely for the CAMCEVI ETM leuprolide subcutaneous injection emulsion.*

FDA Label Image

Image5 (Camcevi Inj Image 5)

An instructional diagram of a subcutaneous injection device for CAMCEVI ETM (leuprolide) 21 mg/.3g emulsion. The diagram labels the components: Needle and Cover, Product, Barrel, End Stopper, Backstop, and Plunger Rod for proper identification of parts during administration.*

FDA Label Image

Image6 (Camcevi Inj Image 6)

An illustration showing a hand pinching the skin on the abdominal area, indicating the site for subcutaneous injection administration.*

FDA Label Image

Image7 (Camcevi Inj Image 7)

An instructional diagram showing two hands preparing a subcutaneous injection. The left hand is pulling the cap off a needle, indicated by an orange arrow, while the right hand is holding the syringe at an angle, suggesting a step in the injection preparation process.*

FDA Label Image

Image8 (Camcevi Inj Image 8)

An instructional diagram illustrating the subcutaneous injection of CAMCEVI ETM (leuprolide) injection emulsion. The diagram shows a hand holding a syringe inserted at a 90-degree angle into the skin, demonstrating the correct injection technique.*

FDA Label Image

Image Description (Camcevi Inj Image 9)

Instructional illustration showing the steps to prepare and activate a CAMCEVI ETM (leuprolide) injection emulsion for subcutaneous use. The images depict hand motions: pushing and twisting a component, followed by audible 'click' signals indicating proper assembly or activation of the injection device.*

FDA Label Image

Image10 (Camcevi Inj Structure)

Chemical structure of leuprolide as shown in the image, depicting its molecular formula including amino acid residues and sulfate group representation.*

FDA Label Image

Image11 (Camcevi Inj Figure 1)

A line graph showing serum testosterone percent change over time in days, with a steep initial increase followed by a rapid decline to near -100%, maintained through day 168. The y-axis represents serum testosterone percent change with 95% confidence intervals, and the x-axis shows days up to 168. Sample sizes vary across time points.*

FDA Label Image

Blister (Camcevi Inj Blister Label)

Label for CAMCEVI ETM (leuprolide) injection emulsion, 21 mg, single-dose pre-filled syringe for subcutaneous use. The blister carton contains one sterile pre-filled syringe. Storage instructions include refrigeration at 2°C to 8°C, protecting from light, and not freezing or shaking. Manufactured for Foresee Pharmaceuticals Co., Ltd., with production in France by Fareva Pau.*

FDA Label Image

Carton-label (front) (Camcevi Inj Carton Label Front)

The image shows the carton packaging for CAMCEVI ETM (leuprolide) injection emulsion in a 21 mg single-dose pre-filled syringe. The label states it is for subcutaneous injection once every 3 months, manufactured by Foresee Pharmaceuticals Co., Ltd. The package includes dosage and storage instructions, with branding and barcode labels visible.*

FDA Label Image

Carton-label (back) (Camcevi Inj Carton Label Back)

Instructions for syringe assembly, injection site preparation, treatment administration, and needle protection for CAMCEVI ETM 21 mg/leuprolide subcutaneous injection emulsion. The diagram includes step-by-step visuals for removing syringe components, attaching the needle, preparing the injection site, administering the injection at a 90-degree angle, and activating the needle safety sheath after use.*

FDA Label Image

Syringe (Camcevi Inj Syringe Label)

CAMCEVI ETM (leuprolide) injectable emulsion label showing a 21 mg single-dose pre-filled syringe for subcutaneous injection. The label includes the product name, active ingredient, strength, dosage form, route, and manufacturer Foresee Pharmaceuticals Co., Ltd. It also notes prescription status and contains a barcode and placeholders for expiration and lot numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.